当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析 - 资产负债表

誉衡药业

(002437)

  

流通市值:49.35亿  总市值:53.45亿
流通股本:20.73亿   总股本:22.46亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金468,713,400.56433,920,872.38700,893,734.65711,275,270.6
应收票据及应收账款163,476,719.81198,413,991.14165,902,705.59205,969,515.14
其中:应收票据2,556,237.62467,224.14155,279.7729,323.06
应收账款160,920,482.19197,946,767165,747,425.89205,240,192.08
应收款项融资2,412,4783,826,804.61,818,636.41,699,807.4
预付款项18,976,384.9618,973,521.0713,229,048.8410,245,945.29
其他应收款合计20,530,307.7623,946,081.6321,523,160.0326,651,941.36
存货187,622,761.59185,347,885.46189,035,844.53190,666,605.53
其他流动资产8,694,959.289,706,482.649,958,155.077,940,575.63
流动资产平衡项目0000
流动资产合计870,427,011.96874,135,638.921,102,361,285.111,154,449,660.95
非流动资产:
长期股权投资69,029,790.0369,069,893.2369,231,512.0168,544,332.6
其他权益工具投资78,970,365.778,970,365.780,127,101.3479,974,592.14
其他非流动金融资产140,447,258.27139,292,638.13138,441,989.77149,710,131.91
投资性房地产31,579,101.2131,877,295.932,175,490.6132,473,685.32
固定资产1,028,050,473.91,029,478,059.091,043,412,840.691,055,568,594.1
在建工程4,937,476.696,030,779.253,102,998.693,045,406.14
使用权资产3,733,687.95---
无形资产168,839,597.13176,400,250.01183,829,539.44191,300,356.59
开发支出13,286,626.2312,101,382.2410,231,510.058,230,847.78
商誉369,032,276.3369,032,276.3369,032,276.3369,032,276.3
递延所得税资产19,061,615.5619,380,782.720,263,765.9921,009,217.65
其他非流动资产29,683,713.4534,403,802.2727,654,468.9719,111,003.71
非流动资产平衡项目0000
非流动资产合计1,956,651,982.421,966,037,524.821,977,503,493.861,998,000,444.24
资产平衡项目0000
资产总计2,827,078,994.382,840,173,163.743,079,864,778.973,152,450,105.19
流动负债:
短期借款35,031,388.8980,036,055.55405,451,860.69675,689,728.35
应付票据及应付账款59,264,071.866,551,726.1168,227,449.1569,876,119.26
应付账款59,264,071.866,551,726.1168,227,449.1569,876,119.26
合同负债36,576,813.6749,796,899.5641,149,755.9350,027,377.56
应付职工薪酬90,544,508.9575,415,083.1682,730,193.9684,475,337.98
应交税费32,505,982.9333,283,824.0436,916,776.1237,253,543.8
其他应付款合计611,940,227.88523,808,828.27527,525,567.43488,622,759.85
应付股利1,226,505.381,226,505.381,226,505.381,226,505.38
一年内到期的非流动负债1,000,666.672,502,694.431,000,000-
其他流动负债4,989,319.326,334,546.945,199,035.546,283,406.22
流动负债平衡项目0000
流动负债合计871,852,980.11837,729,658.061,168,200,638.821,412,228,273.02
非流动负债:
长期借款8,505,666.6732,534,944.4419,000,000-
租赁负债3,678,812.72---
递延收益16,805,223.1917,042,358.6420,279,494.0917,873,938.63
递延所得税负债11,698,491.9911,832,822.5911,972,812.7712,117,073.91
非流动负债平衡项目0000
非流动负债合计40,688,194.5761,410,125.6751,252,306.8629,991,012.54
负债平衡项目0000
负债合计912,541,174.68899,139,783.731,219,452,945.681,442,219,285.56
所有者权益(或股东权益):
实收资本(或股本)2,280,693,9502,270,513,9502,270,513,9502,198,122,950
资本公积450,408,698.52443,332,821.92402,430,274.78380,472,624.78
减:库存股103,213,750---
其他综合收益-8,078,702.28-7,464,975.59-7,619,073.11-7,690,401.28
专项储备4,127,197.384,127,415.384,375,197.774,375,197.77
未分配利润-730,021,261.38-788,536,257.25-861,224,114.2-913,507,023.79
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,893,916,132.241,921,972,954.461,808,476,235.241,661,773,347.48
少数股东权益20,621,687.4619,060,425.5551,935,598.0548,457,472.15
股东权益平衡项目0000
股东权益合计1,914,537,819.71,941,033,380.011,860,411,833.291,710,230,819.63
负债和股东权益合计2,827,078,994.382,840,173,163.743,079,864,778.973,152,450,105.19
公告日期2024-10-292024-08-242024-04-272024-04-20
审计意见(境内)标准无保留意见
TOP↑